MicroRNAs are enriched at COVID-19 genomic risk regions, and their blood levels correlate with the COVID-19 prognosis of cancer patients infected by SARS-CoV-2.
Autor: | Anfossi, Simone1 (AUTHOR) sanfossi@mdanderson.org, Darbaniyan, Faezeh2 (AUTHOR), Quinlan, Joseph1 (AUTHOR), Calin, Steliana3 (AUTHOR), Shimizu, Masayoshi1 (AUTHOR), Chen, Meng1 (AUTHOR), Rausseo, Paola1 (AUTHOR), Winters, Michael4 (AUTHOR), Bogatenkova, Elena5 (AUTHOR), Do, Kim-Anh6 (AUTHOR), Martinez, Ivan4 (AUTHOR), Li, Ziyi6 (AUTHOR), Antal, Loredana7 (AUTHOR), Olariu, Tudor Rares7,8 (AUTHOR), Wistuba, Ignacio1 (AUTHOR), Calin, George A.1,9 (AUTHOR) gcalin@mdanderson.org |
---|---|
Zdroj: | Molecular Cancer. 10/21/2024, Vol. 23 Issue 1, p1-17. 17p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |